← USPTO Patent Grants

Vasopressin-2 receptor antagonist peptides and uses thereof

Grant US12595288B2 Kind: B2 Apr 07, 2026

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

Inventors

Nicolas Gilles, Justyna Ciolek, Laura Droctove, Bernard Maillere, Herve Nozach

Abstract

A peptide may include a sequence having 80% or more amino acid identity with the amino acid sequence of SEQ ID NO. 1, i.e., RPSX1CNLPVKPGPCX2GFFSAFYYSQKX3NKCHSFTYGGCAGNANRFSTX4EKCRRTC X5X6, wherein, X1 is the amino acid residue F or G, X2 is any amino acid residue, except a basic amino acid residue, X3 is the amino acid residue T or D, X4 is the amino acid residue I, L, or E, (i) X5 is V and X6 is G or (ii) X5 is G and X6 is V, and the amino acid located at position 39 is A. Such peptides may have various diagnostic and therapeutic uses.

CPC Classifications

C07K 14/46 A61K 38/17 C12N 15/63 G01N 33/5008 G01N 2333/72

Filing Date

2021-06-23

Application No.

18002625

Claims

14